<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03215173</url>
  </required_header>
  <id_info>
    <org_study_id>17-0045</org_study_id>
    <nct_id>NCT03215173</nct_id>
  </id_info>
  <brief_title>Fit After Baby: A Health Intervention to Increase Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease</brief_title>
  <acronym>FAB</acronym>
  <official_title>Fit After Baby: A Randomized Controlled Trial of a Mobile Health Intervention to Increase Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about how to increase postpartum weight loss and how to
      decrease risk factors for postpartum women at increased risk for diabetes and heart disease.
      The program is delivered using a mobile application (app) and a lifestyle coach. This mobile
      application is developed for women who are at higher risk for diabetes and heart disease.
      Women who have gestational diabetes, (diabetes during pregnancy, or GDM), gestational
      hypertension (high blood pressure), and/or preeclampsia (high blood pressure and protein in
      the urine), and/or small-for gestational-age, and/or preterm (early) delivery during their
      pregnancies have a higher risk for diabetes and heart disease. This mobile application was
      developed using the latest research studies and using the evidence-based Diabetes Prevention
      and Colorado Weigh programs. The goal of the program is to help women lose weight and
      participate in physical activity after delivery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in weight loss from baseline to one year postpartum</measure>
    <time_frame>Baseline (~6 weeks), 6 months, and 12 months</time_frame>
    <description>Documentation of any change in weight at one year postpartum compared to weight at baseline, 6 weeks, 6 months and 12 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in postpartum weight retention</measure>
    <time_frame>Pre-pregnancy, 6 weeks, 6 months, and 12 months</time_frame>
    <description>Documentation of any change in postpartum weight at one year postpartum compared to pre-pregnancy weight at 6 weeks, 6 months and 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Subject Satisfaction</measure>
    <time_frame>Weekly from Baseline (~6 weeks) to 18 weeks postpartum and then at 6 months and 12 months postpartum</time_frame>
    <description>Subject satisfaction will be documented using a Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to self monitoring</measure>
    <time_frame>Daily from Baseline to 18 weeks postpartum and then at 6 months and 12 months postpartum</time_frame>
    <description>Frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of app</measure>
    <time_frame>Daily from Baseline to 12 months postpartum</time_frame>
    <description>Frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of interactions with lifestyle coach</measure>
    <time_frame>Daily from Baseline to 12 months postpartum</time_frame>
    <description>Number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in waist circumference</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Change in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting glucose</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Change in mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Change in %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting insulin</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Change in fasting insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in adiponectin</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Change in adiponectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lipids</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>HDL, LDL, Triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Change in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hsCRP</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Change in hsCRP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in postnatal depression score</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Edinburgh Postnatal Depression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Physical activity</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Modified Pregnancy Physical Activity Questionnaire (PPAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Social Support</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Social Support for Eating Habits Survey; Social Support for Physical Activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Self-Efficacy</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Self Efficacy Survey for Diet and Exercise Behaviors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Perceived Stress</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Perceived Stress Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>2005 Block FFQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in breastfeeding status</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Breastfeeding frequency and intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Readiness to Change</measure>
    <time_frame>Baseline to 6 months and to 12 months</time_frame>
    <description>Readiness to Change Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Diabetes</condition>
  <condition>Gestational Diabetes</condition>
  <condition>Preeclampsia</condition>
  <condition>Gestational Hypertension</condition>
  <condition>Small for Gestational Age at Delivery</condition>
  <condition>Preterm Birth</condition>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>Fit After Baby Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fit After Baby mobile health lifestyle intervention to increase postpartum weight loss, increase postpartum physical activity, and improve postpartum diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Text4Baby Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Receive text messages from the free Text4Baby program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Fit After Baby</intervention_name>
    <description>Mobile application</description>
    <arm_group_label>Fit After Baby Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Text4Baby Control Group</intervention_name>
    <description>Receive free text messages</description>
    <arm_group_label>Text4Baby Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18-45

          2. Postpartum Body Mass Index (BMI): 26- 45 kg/m2 (â‰¥24 for Asians)

          3. Positive history of one or more of the following complications in most recent
             singleton or twin pregnancy:

               1. Gestational diabetes mellitus (by Carpenter-Coustan criteria, IADPSG
                  (International Association of the Diabetes and Pregnancy Study Groups) criteria,
                  or a documented clinical diagnosis). Women with a glucose value &gt;200 mg/dL after
                  a 50-g glucose challenge test at &gt;12 weeks gestation will also be included.

               2. Preeclampsia (high blood pressure and proteinuria diagnosed after 20 weeks
                  gestation)

               3. Gestational hypertension (new hypertension diagnosed after 20 weeks without
                  proteinuria)

               4. Pre-term delivery (32-37 weeks)

               5. Small for gestational age (&lt;10th percentile for gestational age)

          4. Access to and be willing to use a wi-fi enabled iPhone (5 or higher) or iPod (5 or
             higher).

          5. Capable of providing informed consent

          6. Between 4 weeks and 16 weeks after delivery

        Exclusion criteria include:

          1. Personal history of Type 1 or 2 diabetes

          2. Personal history of breast cancer or any other type of cancer other than a basal cell
             skin cancer;

          3. Personal history of major chronic illness all to be assessed by the study physician
             for ability to participate, including:

               1. cardiovascular disease (coronary artery disease, congestive heart failure,
                  valvular heart disease, stroke, transient ischemic attack, or intermittent
                  claudication),

               2. kidney disease affecting kidney function severe enough to affect participation,

               3. liver disease affecting liver function severely enough to affect participation,

               4. venous or arterial thromboembolic disease,

               5. untreated adrenal insufficiency,

               6. depression requiring hospitalization within the past 6 months, or

               7. non-pregnancy related illness requiring overnight hospitalization in the past 6
                  months;

          4. Underlying disease/treatment that might interfere with participation in/completion of
             the study (e.g. significant gastrointestinal conditions, major psychiatric disorders
             affecting the ability to participate, and others at the discretion of the study
             clinician);

          5. Re-current pregnancy;

          6. Diagnosis of diseases associated with glucose metabolism;

          7. Current or planned participation in a commercial weight loss program (i.e. Jenny
             Craig) over the duration of the study;

          8. Previous or planned bariatric surgery;

          9. Taking certain prescription medications including

               1. high dose glucocorticoids,

               2. atypical antipsychotics associated with weight gain (such as risperdal
                  (risperidone), clozapine (clozaril), olanzapine (zyprexa), quetiapine (seroquel),
                  etc.) or

               3. weight loss medications including prescription (Qsymia, phentermine, topiramate,
                  Belviq, Contrave, Saxenda, Orlistat), or non-prescription (Alli) medications;

         10. Taking metformin or other medications known to affect glucose metabolism;

         11. Other active medical problems detected by examination or laboratory testing, at the
             discretion of the physician;

         12. Any fasting blood glucose &gt; 126 mg/dl, any HbA1c at or above 6.5%, or any plasma
             glucose &gt;200 mg/dl during the first trimester.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacinda Nicklas, MD, MPH, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacinda Nicklas, MD, MPH, MA</last_name>
    <phone>(303)724-9028</phone>
    <email>jacinda.nicklas@ucdenver.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacinda Nicklas, MD, MPH, MA</last_name>
      <phone>303-724-9028</phone>
      <email>jacinda.nicklas@ucdenver.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2017</study_first_submitted>
  <study_first_submitted_qc>July 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2017</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Hypertension, Pregnancy-Induced</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

